NeuroFlow, a leader in behavioral health technology infrastructure, has announced its acquisition of Owl, a company specializing in measurement-based care. This strategic merger creates a comprehensive suite of solutions designed to identify and manage behavioral health needs across various healthcare settings, solidifying NeuroFlow’s position as a dominant force in the behavioral health measurement and engagement market. This acquisition builds upon NeuroFlow’s previous integration of Capital Solution Design, further expanding its reach into behavioral health provider organizations and enabling seamless integration across primary and specialty care.
The combined entity aims to provide a 360-degree view of a population’s behavioral health risks, tackling systemic barriers to accessing care. This initiative is crucial as behavioral health conditions are pervasive, often going unrecognized and untreated, leading to increased healthcare costs and poorer patient outcomes. NeuroFlow’s platform, now augmented by Owl’s capabilities, will empower providers, health plans, and government agencies to better address these challenges.
“Behavioral health conditions are present everywhere, not just in behavioral health clinics, and in many cases those conditions go unidentified or untreated, leading to higher costs and worse clinical outcomes. That is why NeuroFlow has historically been focused on upstream needs with payers, primary care, and other multi-specialty providers,” explained NeuroFlow Chief Executive Officer Chris Molaro. “As the leading measurement-based care solution for behavioral health providers, Owl provides a comprehensive solution for monitoring patients who need a higher level of care, giving providers the tools to track and measure outcomes over time and ensure quality and consistency throughout the care journey. This is just the beginning; we intend to build on this comprehensive foundation to improve access and engagement.”
This merger establishes the largest end-to-end behavioral health measurement solution available, equipping providers with the tools to identify, stratify, and coordinate care for behavioral health needs effectively. The integrated platform will offer over 400 behavioral health assessments, available in multiple languages, and leverage robust analytics from diverse data sources, including patient-reported outcomes and retrospective health data. NeuroFlow’s AI and NLP technology will play a critical role in identifying individuals at risk, including those experiencing suicidal ideation. Furthermore, a recent impact study involving Owl and Colorado Access demonstrated the significant positive effects of consistent behavioral health measurement on care quality and overall cost reduction, a success NeuroFlow is keen to replicate nationwide.
“Owl is dedicated to improving clinical outcomes in partnership with behavioral health providers and demonstrating meaningful savings for the healthcare ecosystem,” stated Eric Meier, Chief Executive Officer at Owl, who will now serve as NeuroFlow’s President of Behavioral Health Markets. “We’re looking forward to expanding the impact of our technology with NeuroFlow’s team and resources. Together, our organizations will provide a truly comprehensive solution that simplifies identification of individuals in need of behavioral health care and guides them through their treatment journey. Ultimately, this merger means we can make the greatest impact on behavioral health outcomes across the healthcare spectrum.”
The combined company will manage over 17 million lives on its platform and serve payers and providers across all 50 states. This expansion significantly enhances the solutions and services offered to existing partners, with a continued focus on customer collaboration and innovation.
Dr. Tom Hawes, a physician and Managing Director of the Blue Venture Fund, an investor in Owl, commented on the merger’s significance: “Behavioral health acuity continues to rise, requiring more sophisticated solutions to solve the problem of access. We can’t simply add more providers to address this issue; we need effective solutions to identify behavioral health risk early and seamlessly connect individuals to the right care at the right time. This merger creates a company that can provide a true 360-degree view of individual and population behavioral health enabling value-based care at scale.”
About NeuroFlow
NeuroFlow empowers risk-bearing healthcare organizations to enhance outcomes and manage the cost of care for medically complex populations by identifying and addressing often-undetected behavioral health needs. Their scalable technology and analytics capabilities provide crucial behavioral health insights to payers, providers, and federal government entities, enabling sustainable population management. With deep expertise in whole-person care, NeuroFlow facilitates risk predictability and proactive care, addressing systemic challenges within the current healthcare ecosystem.
About Owl
Owl offers a comprehensive behavioral health solution designed to help organizations deliver high-quality care and improve patient outcomes. Their measurement-based care platform provides healthcare providers with precise data and insightful analytics to refine treatment strategies. Owl’s vision is to foster a healthier world by increasing access to care, enhancing outcomes, and aligning payers and providers for superior results. Discover the power of measurement-based care at owl.health, where superior data and insights lead to better outcomes for everyone.
